Table 3 Cancer type and stage of patients receiving non-cisplatin based chemotherapy
Site of cancer | Stage of tumor (N = 200) | Total (%) | ||
|---|---|---|---|---|
Early (%) | Locally advanced (%) | Metastatic (%) | ||
Lung | 1 (0.5) | 6 (3) | 7 (3.5) | 14 (7) |
Gastric/GEJ | 0 | 8 (4) | 8 (4) | 16 (8) |
Pancreatic | 0 | 8 (4) | 6 (3) | 14 (7) |
Ovarian | 0 | 7 (3.5) | 9 (4.5) | 16 (8) |
Endometrial | 0 | 3 (1.5) | 3 (1.5) | 6 (3) |
Breast | 4 (2) | 28 (14) | 28 (14) | 60 (30) |
Colorectal/Anal/Small bowel | 5 (2.5) | 17 (8.5) | 22 (11) | 44 (22) |
Lymphomaa | 1 (0.5) | 11 (5.5) | 12 (6) | |
Sarcoma | 1 (0.5) | 7 (3.5) | 4 (2) | 12 (6) |
Others | 0 | 1 (0.5) | 5 (2.5) | 6 (3) |